Genmab earns million-dollar milestone payment
![Foto: Genmab, PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article8006510.ece/ALTERNATES/schema-16_9/genmab-office-interior.jpg)
The publicl biotech group Genmab has become USD 3 million richer Monday afternoon after receiving a milestone payment relating to its DuoBody platform collaboration with US drug company Janssen, it says in a stock market release.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Daratumumab up for accelerated assessment in EU
For abonnenter
Genmab’s sBLA for Arzerra granted Priority Review
For abonnenter
New advance for Genmab's blockbuster in the making
For abonnenter